Delgada
Deoxycholic acid injection · 8 mL × 5 vials · Korea · professional use only.
$64.90
You save
Delgada is a Korean-made deoxycholic acid injection for localized fat reduction in the face and body, sharing the same active ingredient class as Kybella but sold as a separate, non-FDA-approved product.
Professional use only. This product is intended for administration by licensed healthcare practitioners trained in the relevant anatomy and injection technique. By ordering you confirm you are authorised to purchase and handle products of this class in your jurisdiction. Availability and permitted use vary by country — please verify local regulations before ordering.
Did you like this product? Add to favorites now and follow the product.
(+82) 10 7364 7998 Send a message on WhatsApp.
Delgada: a deoxycholic acid contouring solution
Delgada is an injectable solution based on deoxycholic acid, a bile acid that helps the body digest dietary fat. It is supplied as 8 mL vials, 5 per box, and is made in South Korea. Practitioners use it for localised fat contouring.
The only FDA-approved deoxycholic acid injection is Kybella, approved for moderate to severe fullness under the chin. Delgada is a different product that has not been evaluated by the US FDA. It is for use by licensed professionals only.
A bile acid used in injectable lipolysis solutions.
8 mL vials in the manufacturer's original packaging.
Kybella is the only FDA-approved deoxycholic acid injection. Delgada is a separate product.
An injectable for trained professionals. Follow the manufacturer's instructions.
About Delgada
Deoxycholic acid is the lipolytic agent.
5 vials of 8 mL per box.
Made in South Korea.
Safety information from the Kybella US label is included below as a guide to the class.
Treatment areas and indications
Concerns where deoxycholic acid solutions are used in practice.
Localised fullness beneath the chin, the area where Kybella is approved.
Small areas of fat on the body. This is use outside any FDA approval and is governed by local rules.
Delgada is an injectable product. Which indications are permitted, how it is classified and what training is required are set by the regulatory framework where you practise. Nothing here is a recommendation to treat any medical condition.
Delgada at a glance
| Product type | Deoxycholic acid solution for injection |
| Active | Deoxycholic acid |
| Pack | 8 mL × 5 vials per box |
| Origin | South Korea |
| Used for | Localised fat contouring |
| Storage | As stated in the manufacturer's instructions for use |
Before you order
- Delgada has not been evaluated by the US FDA. Kybella is the only FDA-approved deoxycholic acid injection and is approved only for submental fullness. FDA has warned about use outside that area. Regulation differs by country, so confirm what applies where you practise.
- Every product ships in its original packaging with the lot number and expiry date.
- We do not dispatch stock with under 6 months of shelf life remaining unless agreed in advance.
Quantity discounts apply at five, ten and twenty boxes.
What each component does
Deoxycholic acid
Deoxycholic acid is a secondary bile acid. Injected into subcutaneous fat, it damages fat cell membranes, and the body clears the released contents. Kybella is the only deoxycholic acid injection approved by the US FDA, and only for submental fullness. The full ingredient list is in the manufacturer’s instructions for use.
How it works
Deoxycholic acid disrupts the membranes of fat cells in the injected area, and the body clears the released contents. This effect is not selective, so nearby tissue can also be affected, which explains the risks above.
How Delgada is used
Reference information for trained practitioners. The manufacturer’s instructions for use and training take precedence over this page, including depth, volume per point and number of sessions.
Step by step
-
Assess and consent
Confirm the concern is localised fat. Explain the risks below, that results build gradually and vary, and that this is not a weight-loss treatment.
-
Map the anatomy
For the lower face, locate the marginal mandibular nerve and avoid the vessels and glands. Mark the area.
-
Prepare the skin and vial
Cleanse the skin. Inspect the vial, seal and expiry, and draw up aseptically.
-
Inject as instructed
Inject into the subcutaneous fat layer using the depth, volume and spacing in the manufacturer’s instructions.
-
Plan the course
The number and spacing of sessions follow the manufacturer’s instructions.
-
Aftercare
Warn the patient that swelling, bruising and numbness are common, and to report trouble swallowing, an uneven smile, severe pain or skin changes.
Administration notes
Describe the result honestly. Delgada is used for localised contouring. It does not treat obesity, and results vary.
- Single use. Discard any remainder after drawing up.
- Do not inject into infected, inflamed or broken skin.
- Dispose of needles into a sharps container in line with local clinical waste rules.
After treatment
- Marked swelling, bruising, pain and numbness are common
- Seek review for difficulty swallowing, an uneven smile, skin ulceration or a firm lump
Storing and handling Delgada
Store away from direct light, as stated in the manufacturer’s instructions for use.
Check the vial, seal and expiry. Do not use a vial that is damaged, discoloured or contains visible particles.
Single patient, single session. Do not retain or reuse an opened vial.
Do not use if the packaging is damaged or the expiry date has passed. Dispose of used vials, syringes and needles as clinical waste in line with local requirements.
What's included with Delgada
Needles and syringes are not supplied.
Delgada — frequently asked questions
What is Delgada?
A deoxycholic acid injection from South Korea, supplied as 8 mL vials, 5 per box, for localised fat contouring by professionals.
Is Delgada the same as Kybella?
No. Kybella is the only FDA-approved deoxycholic acid injection, for submental fullness. Delgada is a separate product and has not been evaluated by the US FDA.
What are the main risks?
For deoxycholic acid under the chin, the US label reports temporary marginal mandibular nerve injury (an uneven smile) in about 4% of patients and trouble swallowing in about 2%, along with swelling, bruising, numbness, and rarely ulceration, tissue death or infection.
Can it be used outside the chin area?
The FDA has warned about use outside the submental area. Follow the manufacturer’s instructions and your local rules.
Who can buy and use this product?
Injectable products are for administration by licensed professionals. We supply qualified professionals and do not sell to consumers.
Copyright 2026 © Korea Filler Experts. All right reserved.
